MONDAY, Jan. 5 — Deanna Babcock’s heart stopped beating on July 20, 2007. Just like that.
“I was swimming in a pool at North Carolina State University, doing normal laps,” recalled Babcock, who was 23 years old and in excellent health, or so she thought. “My strokes started getting sloppy, and I coasted to a stop face down.”
Jim Stoltz’s heart stopped on July 20, 2009. “I was sitting at my desk,” said Stoltz, 66, who is an accountant who lives in Flanders, N.J. “I don’t recall much. I simply went under my desk. I woke up five days later in the hospital.”
Read the rest of this entry »
January 12th, 2009 | Posted in Breast Cancer, Lung Cancer | Tags: Beating, Heart, stops, When
Cell Genesys Inc. shares dropped sharply today as the South San Francisco company said it will cut more than 200 jobs, is exploring its sale or liquidation, and stopping the late-stage trial of its prostate cancer drug.
The company (NASDAQ: CEGE) also said it was terminating the employment of Chief Medical Officer Robert Dow.
Cell Genesys shares were down 45 cents — or 73 percent — to 17 cents per share in mid-day trading.
Read the rest of this entry »
January 5th, 2009 | Posted in News, Prostate Cancer | Tags: cancer, Cell, explores, Genesys, Prostate, sale, stops, trial
Cell Genesys Inc. shares dropped sharply today as the South San Francisco company said it will cut more than 200 jobs, is exploring its sale or liquidation, and stopping the late-stage trial of its prostate cancer drug.
The company (NASDAQ: CEGE) also said it was terminating the employment of Chief Medical Officer Robert Dow.
Cell Genesys shares were down 45 cents — or 73 percent — to 17 cents per share in mid-day trading.
Read the rest of this entry »
January 4th, 2009 | Posted in News, Prostate Cancer | Tags: cancer, Cell, explores, Genesys, Prostate, sale, stops, trial